Delivery Order SPE2DB24D2018-SPE2DB25FWVL3

AmerisourceBergen Drug Corp has been awarded a delivery order valued at $2,085.12 by the Defense Logistics Agency (DLA) for the supply of Varivax vaccine with diluents. The award, issued on July 7, 2025, with an ultimate completion date of July 28, 2025, carries a firm fixed price structure and represents a competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for supplying pharmaceuticals and medical supplies to support military healthcare programs globally.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capacity to meet federal medical procurement requirements through its extensive portfolio of federal contracts with the DLA Medical Supply Chain. The company's competitively awarded delivery orders, which typically employ firm fixed pricing, encompass a broad spectrum of pharmaceutical products including vaccines, medications, and specialized medical supplies supporting military and veteran healthcare systems. This particular vaccine procurement aligns with the company's established role as a critical vendor for the Defense Health Agency and other government healthcare systems within the federal medical supply ecosystem.